Cargando…

Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer

The aim was to investigate gender differences in the likelihood to receive metastatic surgery, and to compare overall survival between men and women, among patients with synchronous metastatic colorectal cancer (mCRC) in a population‐based setting. All Swedish adult patients diagnosed with synchrono...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ljunggren, Malin, Weibull, Caroline E., Palmer, Gabriella, Osterlund, Emerik, Glimelius, Bengt, Martling, Anna, Nordenvall, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Cancer Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086966/ https://www.ncbi.nlm.nih.gov/pubmed/36000990 http://dx.doi.org/10.1002/ijc.34255

Ejemplares similares

Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
por: Ljunggren, Malin, et al.
Publicado: (2022)

Low‐dose aspirin use and colorectal cancer survival in 32,195 patients—A national cohort study
por: Shahrivar, Mehrnoosh, et al.
Publicado: (2022)

Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?
por: Osterman, Erik, et al.
Publicado: (2020)

The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival
por: Brouwer, Nelleke P. M., et al.
Publicado: (2019)

Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone
por: Cavalli-Björkman, N, et al.
Publicado: (2012)

Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data
por: Hamers, Patricia A. H., et al.
Publicado: (2020)

Exposure to oestrogen and risk of anastomotic leakage after colorectal cancer surgery – A clue to the different leak rates in men and women
por: Rutegård, Martin, et al.
Publicado: (2022)

Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis
por: van der Kruijssen, Dave E. W., et al.
Publicado: (2022)

Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)
por: Lehtomäki, Kaisa, et al.
Publicado: (2023)

Autoimmune and Metabolic Diseases and the Risk of Early-Onset Colorectal Cancer, a Nationwide Nested Case–Control Study
por: Lundqvist, Erik, et al.
Publicado: (2023)

Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients
por: Aasebø, Kristine Ø., et al.
Publicado: (2019)

KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer
por: Osterlund, Emerik, et al.
Publicado: (2022)

Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018
por: Board, Ruth, et al.
Publicado: (2020)

Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study
por: Lehtomäki, Kaisa, et al.
Publicado: (2022)

Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing
por: Holm, Matilda, et al.
Publicado: (2020)

Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world database
por: Mailliez, Audrey, et al.
Publicado: (2022)

Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases
por: Dillekås, Hanna, et al.
Publicado: (2014)

Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma
por: Hegewisch‐Becker, Susanna, et al.
Publicado: (2018)

Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact
por: Johansson, Anna L. V., et al.
Publicado: (2018)

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
por: Winther, Stine Braendegaard, et al.
Publicado: (2017)

Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?
por: Broadbridge, V T, et al.
Publicado: (2013)

Assessing relative COVID-19 mortality: a Swiss population-based study
por: Hothorn, Torsten, et al.
Publicado: (2021)

Assessing relative COVID-19 mortality during the second wave: a prospective Swiss population-based study
por: Siegfried, Sandra, et al.
Publicado: (2021)

Mismatch repair status between primary colorectal tumor and metastatic tumor, a retrospective consistent study
por: Wang, Zheng, et al.
Publicado: (2019)

Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma
por: Xie, Shao‐Hua, et al.
Publicado: (2020)

Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
por: Ren, Jin-Xiao, et al.
Publicado: (2018)

Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases
por: Harlid, Sophia, et al.
Publicado: (2022)

Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates
por: Zmuc, Jan, et al.
Publicado: (2023)

Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection
por: Ghiringhelli, Francois, et al.
Publicado: (2014)

Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008
por: Kirac, Iva, et al.
Publicado: (2012)

Plasma metabolites associated with colorectal cancer: A discovery‐replication strategy
por: Geijsen, Anne J.M.R., et al.
Publicado: (2019)

An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients
por: Brouwer, Nelleke P.M., et al.
Publicado: (2018)

Estimating the Effect of Targeted Screening Strategies: An Application to Colonoscopy and Colorectal Cancer
por: Thomas, Duncan C.
Publicado: (2017)

Global and national trends in the age‐specific sex ratio of esophageal cancer and gastric cancer by subtype
por: Wang, Shaoming, et al.
Publicado: (2022)

Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
por: de Cuba, E. M. V., et al.
Publicado: (2016)

Rotating night shift work and colorectal cancer risk in the nurses’ health studies
por: Papantoniou, Kyriaki, et al.
Publicado: (2018)

Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium
por: Geijsen, Anne J.M.R., et al.
Publicado: (2019)

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
por: Guren, Tormod Kyrre, et al.
Publicado: (2017)

Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
por: Hurvitz, Sara A., et al.
Publicado: (2013)

Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women
por: Burón Pust, Andrea, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a3jke7esoab0ikn03i7foo3cdu